Battelle, CMC Pharmaceuticals Secure $53M DOD Contract for Nerve Agent Countermeasure Development
Battelle, a global research and development company, and subcontractor CMC Pharmaceuticals have been awarded a 6.5-year, $53 million contract by the Department of Defense to develop a nerve agent countermeasure. The deal aims to ensure that U.S. military personnel have a stronger chance of surviving and recovering from nerve agent exposure, Battelle said Monday. Under the contract, […] More